Market Introduction
Hemostasis analyzers are devices that measure clotting mechanisms of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners. Constant technical advancement has led to the launch of many innovative drugs, and instruments such as high-performance hemostasis analyzers are projected to fuel demand growth for hemostasis analyzers.
The report provides trends prevailing in the Middle East and Africa hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.
A rising number of medications imposing multiple diagnostic and therapeutic challenges on stressed healthcare systems, leading to a rise in medical devices and pharmaceuticals. Also, the increasing number of cases of chronic conditions has increased, which resulted in an increased use of drugs for combating the virus. During the widespread COVID-19 pandemic, there have been worries about the potential of certain blood pressure medications such as angiotensin converting enzyme inhibitors (ACEi) and angiotensin-converting blockers (ARB). The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptors to facilitate entry into the host cell. This pandemic enhanced the business operation of the various drug manufacturers operating in the hemostasis analyzers market in the region.
Market Overview and Dynamics
The Middle East and Africa hemostasis analyzers market in the Middle East and Africa is expected to grow from US$ 140.69 million in 2021 to US$ 251.51 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. Older people are prone to heart diseases due to weak immunity and other health problems. General aging factors lead to stiffening heart and blood vessels that result in heart disorders. As the age grows, the systolic blood pressure also rises, leading to an incidence of cardiovascular diseases. Thus, in people aged 75 years and above, high blood pressure is a common risk factor for heart conditions. Coronary artery disease and heart failure are the other causes. Although the incidence of arrhythmias encompasses people of all age groups, it is rising significantly among the geriatric population. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. The primary reason for the disease is related to the structural and functional changes in the cardiovascular system associated with aging. The rise in the global geriatric population is leading to a surge in cardiovascular diseases, which, in turn, is propelling the demand for hemostasis analyzers, supporting the market.
In terms of product type, the laboratory analyzer segment accounted for the largest share of the Middle East and Africa hemostasis analyzers market in 2020. In terms of test, the d-dimer test segment accounted for the largest share of the Middle East and Africa hemostasis analyzers market in 2020. In terms of end user, the hospital/clinics segment accounted for the largest share of the Middle East and Africa hemostasis analyzers market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Middle East and Africa hemostasis analyzers market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical databases, among others. Major companies listed in the report are Siemens Healthineers AG , Abbott , Sysmex Corporation , Nihon Kohden Corporation ,THERMO FISHER SCIENTIFIC INC. ,HOFFMANN-LA ROCHE LTD. , Instrumentation Laboratory Company.
Reasons to buy report
Middle East and Africa Hemostasis Analyzers Market Segmentation
By Product Type
By Test
By Country
Companies Mentioned -
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 140.69 Million |
| Market Size by 2028 | US$ 251.51 Million |
| CAGR (2021 - 2028) | 8.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Hemostasis Analyzers Market is valued at US$ 140.69 Million in 2021, it is projected to reach US$ 251.51 Million by 2028.
As per our report Middle East and Africa Hemostasis Analyzers Market, the market size is valued at US$ 140.69 Million in 2021, projecting it to reach US$ 251.51 Million by 2028. This translates to a CAGR of approximately 8.7% during the forecast period.
The Middle East and Africa Hemostasis Analyzers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Hemostasis Analyzers Market report:
The Middle East and Africa Hemostasis Analyzers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Hemostasis Analyzers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Hemostasis Analyzers Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Hemostasis Analyzers Market
